Jose G. Hernandez-Sanchez
Salamanca, CL 37007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Dosing Strategies for High-Alert Medications in Obese Pediatric Patients: A Systematic Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 11, 2026
Pharmacokinetics and Childhood Obesity: Pathophysiological Basis and Challenges in Choosing the Ideal Body Size Descriptor.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 17, 2025
Optimization of Isavuconazole Dosing in Patients with Invasive Fungal Infections Through Therapeutic Drug Monitoring: Real-World Clinical Practice Experience.
Journal: Life (Basel, Switzerland)
Published: April 29, 2025
Population pharmacokinetics of isavuconazole in hematologic patients: implications for model-informed precision dosing.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 10, 2025
Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.
Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.
Journal: Therapeutic advances in gastroenterology
Published: April 09, 2025
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size.
Journal: JCI insight
Published: April 23, 2024
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
Journal: Gastroenterologia y hepatologia
Published: October 24, 2023
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Journal: Pharmacological research
Published: September 20, 2023
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Journal: Pharmacological research
Published: March 13, 2023
Relationship between vedolizumab serum concentrations in the induction phase and early and sustained response in the first year of treatment in patients with ulcerative colitis.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: April 05, 2022
Last Updated: 09/26/2026